Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
Author(s): Christian Mahnkopf , Younghoon Kwon , Nazem Akoum Added: 2 years ago

Imaging & Diagnostics
LAA Morphology and Function and Stroke Risk in AF Patients
Author(s): Katarzyna Dudzińska-Szczerba , Piotr Kułakowski , Ilona Michałowska , et al Added: 1 year ago

Anticoagulation

Imaging & Diagnostics
EHRA 2021: The STROKESTOP-Study
Author(s): Emma Svennberg Added: 2 years ago
Dr Emma Svennberg (Karolinska Institute, Stockholm, SW) summarises the findings from the Systematic ECG Screening for Atrial Fibrillation Among 75-Year-Old Subjects in the Region of Stockholm and Halland, Sweden (STROKESTOP Study). The aim of this study is to determine whether screening for atrial fibrillation by intermittent ECG recording and initiation of anticoagulation treatment among high… View more

Electrophysiology & Arrhythmia
Residual Stroke Risk in Atrial Fibrillation
Author(s): Wern Yew Ding Added: 2 years ago

Electrophysiology & Arrhythmia
Complications in Anticoagulated Patients with AF
Author(s): George D Katritsis , Demosthenes G Katritsis Added: 3 years ago
Atrial fibrillation (AF) is associated with a fivefold increased risk for stroke, a twofold increased risk for dementia, and a tripling of risk for heart failure,1,2,3 while AF genetic risk is strongly associated with cardioembolic stroke.4In the Framingham Heart Study the percentage of strokes attributable to AF increases steeply from 1.5% at 50–59 years of age to 23.5% at 80−89 years of age.5,6… View more

Anticoagulation
Georgios Tsivgoulis
Prof Georgios Tsivgoulis M.D., Ph.D., MSc, FESO, FEAN is Professor of Neurology and Vice-Chairman in the Department of Neurology at the National & Kapodistrian University of Athens, School of Medicine in Greece. He is the Divisional Director of Cerebrovascular Diseases, Director of the Neurosonology Laboratory and Director of Residential Training and the Cerebrovascular Fellowship Program. He is… View more
Amulet™Device In Non-Valvular Atrial Fibrillation (NVAF) - Boris Schmidt
Author(s): Boris Schmidt Added: 6 years ago
This interview with Boris Schmidt from Cardiovascular Center Bethanien, Frankfurt, DE discussesthe AMULET Registry tracking the Amulet™ device in non-valvular atrial fibrillation (NVAF) subjects. Filmed by Radcliffe Cardiology on-site at EHRA 2017. View more

Electrophysiology & Arrhythmia
Author(s): Sunil Kapur , Moussa Mansour Added: 3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than three million Americans.1 The management of AF revolves around the alleviation of symptoms related to an accelerated and irregular ventricular response, and the prevention of cardioembolism, notably stroke. In patients with AF, there is a fivefold increased incidence of embolic stroke.2 The prevention of systemic… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Anti-Thrombotic Regimens for Patients With Atrial Fibrillation Following PCI: A New Era
Author(s): Georg Nickenig , Jur ten Berg Added: 5 years ago

Electrophysiology & Arrhythmia